Omeros (OMER) Accumulated Expenses (2010 - 2026)
Omeros (OMER) reported Accumulated Expenses of $2.0 million for Q1 2026, down 80.15% on a YoY basis from $9.9 million in Q1 2025, and down 93.33% sequentially from $29.4 million in Q4 2025.
Omeros (OMER) Accumulated Expenses (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Accumulated Expenses data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 80.15% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 80.15% YoY), and the FY2025 full-year result was $29.4 million, up 1001.91% from the prior year.
- Accumulated Expenses slipped to $2.0 million in Q1 2026, from $29.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $30.8 million in Q1 2023 to a low of $300000.0 in Q4 2022.
- A 5-year average of $12.4 million and a median of $6.9 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses plunged 91.1% in 2022 and jumped 1566.67% in 2023, its largest moves.
- Tracing OMER's Accumulated Expenses over 5 years: stood at $300000.0 in 2022, then surged by 1566.67% to $5.0 million in 2023, then slumped by 46.66% to $2.7 million in 2024, then jumped by 1001.91% to $29.4 million in 2025, then tumbled by 93.33% to $2.0 million in 2026.
- Business Quant data shows OMER's Accumulated Expenses at $2.0 million in Q1 2026, $29.4 million in Q4 2025, and $25.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 29.39 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Jun 30, 2025 | 26.28 Mn |
| Mar 31, 2025 | 9.88 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 6.93 Mn |
| Jun 30, 2024 | 27.97 Mn |
| Mar 31, 2024 | 8.80 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | 30.82 Mn |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 18.02 Mn |
| Jun 30, 2022 | 5.17 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 4.39 Mn |
| Jun 30, 2021 | 33.32 Mn |